During radiotherapy, the NF-κB signaling pathway is activated after radiation irradiation, which up-regulates the expression of anti-apoptotic proteins, such as Bcl-2, XIAP, etc., while down-regulates the expression of pro-apoptotic proteins, resulting in the resistance of tumor cells to radiotherapy. Here, BCL2 is linked to neoplasm.